Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page has removed a citation for a clinical trial regarding Cabozantinib versus Sunitinib for metastatic renal cell carcinoma, which included important erratum details.
    Difference
    0.4%
    Check dated 2025-05-08T13:09:13.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T05:50:26.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the study, now labeled as v2.15.0, and includes the addition of the term 'Metastatic Renal Cell Carcinoma' and the collaborator 'Merck Sharp & Dohme LLC'.
    Difference
    37%
    Check dated 2025-04-16T14:48:33.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 13, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.1%
    Check dated 2025-04-09T10:22:36.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and last update date of March 13, 2025.
    Difference
    0.1%
    Check dated 2025-04-01T23:41:39.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page has been updated with new dates for events, specifically adding March 2025 dates while removing previous February 2024 dates. The status of recruitment has also been clarified.
    Difference
    0.8%
    Check dated 2025-03-18T10:03:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.